Trials / Completed
CompletedNCT04099043
Cascade CGM 15-day Performance Assessment
Cascade Continuous Glucose Monitor 15-day Performance Assessment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- WaveForm Technologies Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To validate the feasibility of a 15-day wear period of the Cascade CGM system
Detailed description
To assess a 15-day wear period for the Cascade CGM. This study includes ten subjects who will interface with the system and take finger stick BGM glucose values for calibration. The wear period includes four in-clinic days frequent blood draws and eleven at home days at a single testing site.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cascade Continuous Glucose Monitoring System | Continuous Glucose Monitoring for 15 days |
Timeline
- Start date
- 2019-09-28
- Primary completion
- 2019-10-13
- Completion
- 2019-10-13
- First posted
- 2019-09-23
- Last updated
- 2020-04-06
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT04099043. Inclusion in this directory is not an endorsement.